Eiger Biopharmaceuticals, Inc. holds a multiple-award Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) under the GSA Pharmaceuticals and Drugs schedule. This $225,000 contract allows Eiger to provide drugs, pharmaceuticals, and hematology-related products to VA medical facilities through January 2027. Under this FSS contract, the VA National Acquisition Center has awarded two single-award Blanket Purchase Agreements (BPAs) to Eiger. The first is a $204,359.25 BPA for Eiger's drug Zokinvy, used to treat Hutchinson-Gilford progeria syndrome, covering purchases from January 2022 through January 2025. The second is a $205,000 BPA for Zokinvy to treat progeroid laminopathies, in effect through May 2022. These BPAs provide a streamlined acquisition process for this rare disease treatment over their respective periods of performance.
Generated 9/6/24, 9:08 AM